Oncolytics Biotech (Oncolytics Biotech) Price-to-Tangible-Book : 3.84 (As of Apr. 24, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Oncolytics Biotech Price-to-Tangible-Book?

As of today (2024-04-24), Oncolytics Biotech's share price is $1.06. Oncolytics Biotech's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.28. Hence, Oncolytics Biotech's Price to Tangible Book Ratio of today is 3.84.

The historical rank and industry rank for Oncolytics Biotech's Price-to-Tangible-Book or its related term are showing as below:

ONCY' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.84 Med: 4.84 Max: 12.16
Current: 3.93

During the past 13 years, Oncolytics Biotech's highest Price to Tangible Book Ratio was 12.16. The lowest was 1.84. And the median was 4.84.

ONCY's Price-to-Tangible-Book is ranked worse than
63.71% of 1218 companies
in the Biotechnology industry
Industry Median: 2.69 vs ONCY: 3.93

A closely related ratio is called PB Ratio. As of today, Oncolytics Biotech's share price is $1.06. Oncolytics Biotech's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.28. Hence, Oncolytics Biotech's P/B Ratio of today is 3.84.

Oncolytics Biotech Price-to-Tangible-Book Historical Data

The historical data trend for Oncolytics Biotech's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncolytics Biotech Price-to-Tangible-Book Chart

Oncolytics Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

5.68

2.71

5.13

4.89

Oncolytics Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															5.13	4.08	10.20	7.47	4.89

Competitive Comparison of Oncolytics Biotech's Price-to-Tangible-Book

For the Biotechnology subindustry, Oncolytics Biotech's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncolytics Biotech's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncolytics Biotech's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Oncolytics Biotech's Price-to-Tangible-Book falls into.

Oncolytics Biotech Price-to-Tangible-Book Calculation

Oncolytics Biotech's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	1.06	/	0.276
	=	3.84

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Oncolytics Biotech Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Oncolytics Biotech's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncolytics Biotech (Oncolytics Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolytics Biotech Inc (NAS:ONCY) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

ONC:Canada

Address

322 11th Avenue S.W, Suite 804, Calgary, AB, CAN, T2R 0C5

Website

https://www.oncolyticsbiotech.com

Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The primary focus is to advance programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies.